Dubuque Bank & Trust CO Bristol Myers Squibb CO Transaction History

Dubuque Bank & Trust CO

$733 Million
Q3 2023

A detailed history of Dubuque Bank & Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dubuque Bank & Trust CO holds 11,406 shares of BMY stock, worth $647,974. This represents 0.09% of its overall portfolio holdings.

Number of Shares

11,406

Previous 10,611 7.49%

Holding current value

$647,974

Previous $678,000 2.36%

% of portfolio

0.09%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$57.89 - $64.73 $46,022 - $51,460	795 Added 7.49%	11,406 $662,000
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $4,841 - $5,376	-76 Reduced 0.71%	10,611 $678,000
Q1 2023 Apr 13, 2023	SELL	$65.71 - $74.53 $92,191 - $104,565	-1,403 Reduced 11.6%	10,687 $740,000
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $10,956 - $12,974	-160 Reduced 1.31%	12,090 $870,000
Q3 2022 Nov 02, 2022	SELL	$0.13 - $76.84 $55 - $32,657	-425 Reduced 3.35%	12,250 $871,000
Q2 2022 Jul 13, 2022	SELL	$72.62 - $79.98 $2,759 - $3,039	-38 Reduced 0.3%	12,675 $976,000
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $4,180 - $5,012	-68 Reduced 0.53%	12,713 $928,000
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $4,558 - $5,314	-85 Reduced 0.66%	12,781 $797,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $9,999 - $11,713	-169 Reduced 1.3%	12,866 $761,000
Q2 2021 Jul 09, 2021	SELL	$61.91 - $67.42 $114,223 - $124,389	-1,845 Reduced 12.4%	13,035 $871,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $6,646 - $7,474	-112 Reduced 0.75%	14,880 $939,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $180,033 - $204,010	3,118 Added 26.26%	14,992 $930,000
Q3 2020 Oct 28, 2020	SELL	$57.43 - $63.64 $9,475 - $10,500	-165 Reduced 1.37%	11,874 $716,000
Q2 2020 Jul 24, 2020	SELL	$54.82 - $64.09 $5,810 - $6,793	-106 Reduced 0.87%	12,039 $708,000
Q1 2020 Apr 21, 2020	BUY	$46.4 - $67.43 $99,064 - $143,963	2,135 Added 21.33%	12,145 $677,000
Q4 2019 Jan 14, 2020	BUY	$49.21 - $64.19 $39,318 - $51,287	799 Added 8.67%	10,010 $642,000
Q3 2019 Oct 10, 2019	SELL	$42.77 - $50.71 $3,250 - $3,853	-76 Reduced 0.82%	9,211 $467,000
Q2 2019 Jul 10, 2019	BUY	$44.62 - $49.34 $4,685 - $5,180	105 Added 1.14%	9,287 $422,000
Q1 2019 Apr 02, 2019	BUY	$45.12 - $53.8 $3,429 - $4,088	76 Added 0.83%	9,182 $438,000
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $6,533 - $8,472	-134 Reduced 1.45%	9,106 $473,000
Q3 2018 Oct 30, 2018	SELL	$55.19 - $62.25 $14,625 - $16,496	-265 Reduced 2.79%	9,240 $573,000
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $6,830 - $7,863	-114 Reduced 1.19%	9,505 $601,000
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $531,257 - $613,115	9,619	9,619 $613,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Dubuque Bank & Trust CO with notifications on news.

Account

Dubuque Bank & Trust CO Bristol Myers Squibb CO Transaction History